Efficacy News and Research

RSS

Study offers a novel therapeutic option to combat antibiotic-resistant pneumonia

Increases in multidrug-resistance in the bacteria Streptococcus pneumoniae have made it the fourth-leading cause of death associated with antibiotic resistance.

29 Mar 2023

New engineered bioadhesive sealant for more effective surgical wound management

As part of a collaborative effort, scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have employed inventive chemistry to produce an injectable biomaterial with significantly improved adhesive strength, stretchability, and toughness.

29 Mar 2023

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

Researchers found that, despite being heavily immunocompromised, hematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.

29 Mar 2023

Targeting obesity: findings reveal a new molecular pathway involved in energy homeostasis regulation

Study outlines molecular mechanisms to aid the development of new therapies to manage obesity and associated health disorders.

29 Mar 2023

Clockwork in cancer: the importance of the circadian rhythm in the formation and progression of tumors

Researchers reviewed the importance of the circadian rhythm in the formation and progression of tumors.

29 Mar 2023

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

In a recent study published in the BMC Medicine Journal, researchers conducted a modeling study to evaluate the cost-effectiveness and health impacts of the next-generation vaccines against influenza in Kenya.

28 Mar 2023

The rise of Candida auris: Understanding its origin and persistence

In a recent study published in the PLOS Pathogens journal, researchers from the University of Texas Health Science Center at San Antonio in the United States (US) explored the existing perspectives on the origination, resistance, and transmission of Candida auris, a human fungal pathogen.

28 Mar 2023

3D cell culture system tests how inhibiting fibroblast activities can help treat lung cancer

Fibroblasts build and maintain the extracellular matrix, or physical scaffolding for cells, in the connective tissues within the body.

28 Mar 2023

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Researchers assessed the impact of BCG vaccination on the protection provided by SARS-CoV-2 vaccination.

28 Mar 2023

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

How can Europe tackle its unfinished tuberculosis business?

A recent Eurosurveillance journal editorial discussed the progress in the EU/EEA, between 2018 and 2021, towards achieving the 2030 targets for TB elimination.

27 Mar 2023

New primary care program for older adults lacks clinical benefits

A primary care program promoting the health of older adults was well received by family medical practices but lacked clinical benefits, says a study led by McMaster University researchers, published in the Annals of Family Medicine.

27 Mar 2023

Targeting the STING pathway with a combination strategy promotes antitumor activity

Immunotherapies have greatly improved the outcomes of many patients with melanoma. But there is still a need for new approaches for the subset of patients who do not respond well to this type of therapy.

27 Mar 2023

New ways to increase work participation and quality of life among individuals with disabilities

The unemployment rate for persons with disabilities in the United States, particularly youth, is more than double the rate of those without a disability.

27 Mar 2023

Researchers isolate an IgM exhibiting ultrapotent neutralization from a Zika virus-infected pregnant woman

A recent study published in the Cell Press Journal demonstrated that plasma immunoglobulins of isotype M elicited during pregnancy have an exceptional Zika virus-neutralizing potential.

27 Mar 2023

SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation

SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which aims to accelerate wound debridement, has announced the completion of its GBP 10.9m (c. USD 13.3m) Series B investment round. The funding round was led by Seneca Partners and also included industry veterans, institutional venture and strategic investors, including BRAIN Biotech AG, EVA Pharma, Jonathan Milner, and Wealth Club.

From SolasCure 27 Mar 2023

Efficacy News and Research

Study offers a novel therapeutic option to combat antibiotic-resistant pneumonia

New engineered bioadhesive sealant for more effective surgical wound management

Hematology patients generate robust immune responses against SARS-CoV-2 after vaccination

Targeting obesity: findings reveal a new molecular pathway involved in energy homeostasis regulation

Clockwork in cancer: the importance of the circadian rhythm in the formation and progression of tumors

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

The rise of Candida auris: Understanding its origin and persistence

3D cell culture system tests how inhibiting fibroblast activities can help treat lung cancer

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

New study suggests broad neutralizing antibody could provide three years of COVID protection

How can Europe tackle its unfinished tuberculosis business?

New primary care program for older adults lacks clinical benefits

Targeting the STING pathway with a combination strategy promotes antitumor activity

New ways to increase work participation and quality of life among individuals with disabilities

Researchers isolate an IgM exhibiting ultrapotent neutralization from a Zika virus-infected pregnant woman

SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

Intermittent fasting shows potential benefits for obesity treatment and brain-gut-microbiome health

Advancements in understanding and treating breast cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News